Clinical investigation of Mytomycin intravesical instillation soon after radical nephroureterectomy in patients with upper uriniary tract carcinoma - Mytomycin intravesical instillation after nephroureterectomy

MMC intravesical instillation soon after doing radical nephrectomy was safe. Bladder recurrence in each condition was 25% in Ta, 67% in T1, and 100% in T3 as mentioned in other reported cases. According to the bladder cancer guideline, bladder recurrence in upper tract urothelial carcinoma was reported to be 15-50%. In conclusion, we believe that MMC intravesical instillation soon after radical nephrectomy has the potential to reduce bladder recurrence in patients with upper tract urothelial carcinoma.